Small Molecule Discovery
Hyper Screeing X
Hyper Screening X generates molecules with high synthetic feasibility and binding affinity by exploring an ultra-large chemical space built from commercial building blocks and common reactions.
Explore vast space for Greater discovery success
Explore vast space for Greater discovery success
Hyper Screening X searches a massive 11-trillion-compound virtual library to uncover novel and diverse molecules.
Efficiently navigate an expansive chemical space—unfeasible with traditional virtual screening—using cutting-edge generative AI.
The Hyper Screening X library continues to grow, expanding your discovery potential.
Find molecules tailored to your target
Why settle for the same AI? Hyper Screening X customizes the AI training to fit your project’s unique needs.
Define physicochemical conditions for molecules alongside the target protein.
Use trained AI models to generate condition-specific molecules as many times as needed.
Access building blocks and Synthesis routes
Hyper Screening X generates molecules using purchasable building blocks and feasible chemical reactions.
Generated molecules achieve over 80% synthesizability,* ensuring reliable synthesis outcomes.
* Validated by Synple Chem synthesis service.
Request synthesis quotes and Purchase Building Blocks
Easily get synthesis quotes for your generated molecules directly through HyperLab.
Browse building block prices, suppliers, and delivery times in one interface.
Leverage the power of the generative AI
Hyper Screening X is powered by RxnFlow, a state-of-the-art generative AI for molecule discovery [ICLR 2025].
RxnFlow constructs molecules by combining building blocks through chemical reactions, overcoming unnatural structures and low synthesizability issues common in traditional generative AI designs.
Flexibly train AI to generate molecules meeting complex conditions, even across countless possibilities.
* Seunghwan Seo et al. ICLR 2025 (arXiv:2410.04542).
Explore vast space for Greater discovery success
Hyper Screening X searches a massive 11-trillion-compound virtual library to uncover novel and diverse molecules.
Efficiently navigate an expansive chemical space—unfeasible with traditional virtual screening—using cutting-edge generative AI.
The Hyper Screening X library continues to grow, expanding your discovery potential.
Find molecules tailored to your target
Why settle for the same AI? Hyper Screening X customizes the AI training to fit your project’s unique needs.
Define physicochemical conditions for molecules alongside the target protein.
Use trained AI models to generate condition-specific molecules as many times as needed.
Access building blocks and Synthesis routes
Hyper Screening X generates molecules using purchasable building blocks and feasible chemical reactions.
Generated molecules achieve over 80% synthesizability,* ensuring reliable synthesis outcomes.
Request synthesis quotes and Purchase Building Blocks
Easily get synthesis quotes for your generated molecules directly through HyperLab.
Browse building block prices, suppliers, and delivery times in one interface.
Leverage the power of the generative AI
Hyper Screening X is powered by RxnFlow, a state-of-the-art generative AI for molecule discovery [ICLR 2025].
RxnFlow constructs molecules by combining building blocks through chemical reactions, overcoming unnatural structures and low synthesizability issues common in traditional generative AI designs.
Flexibly train AI to generate molecules meeting complex conditions, even across countless possibilities.
* Seunghwan Seo et al. ICLR 2025 (arXiv:2410.04542).
Ready to revolutionize
Your drug discovery process?
Sign up with your email and start using HyperLab right now
—
AI drug discovery Platform
HITS Inc.
CEO : Woo Youn Kim
Address : 8F, 28, Teheran-ro 4-gil, Gangnam-gu, Seoul, Republic of Korea
© HITS Inc. All rights reserved.
Ready to revolutionize
Your drug discovery process?
Sign up with your email and start using HyperLab right now
—
AI drug discovery Platform
Small Molecule Discovery
Publications
HITS Inc.
CEO : Woo Youn Kim
Address : 8F, 28, Teheran-ro 4-gil, Gangnam-gu, Seoul, Republic of Korea
© HITS Inc. All rights reserved.
Ready to revolutionize
Your drug discovery process?
Sign up with your email and start using HyperLab right now
HITS Inc.
CEO : Woo Youn Kim
Address : 8F, 28, Teheran-ro 4-gil, Gangnam-gu,
Seoul, Republic of Korea
© HITS Inc. All rights reserved.
Small Molecule Discovery
Hyper Screening X generates molecules with high synthetic feasibility and binding affinity by exploring an ultra-large chemical space built from commercial building blocks and common reactions.
Hyper Screeing X
Small Molecule Discovery